Conditions: Healthy Pulmonary Disease, Chronic Obstructive
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 32
Healthy volunteers: yes

Brief summary:
This clinical trial is intended to investigate a possible effect of the p-gp inhibitor ketoconazole on the bioavailability of olodaterol

Detailed description:

Arms:
arm 1: solution for oral inhalation arm 2: tablet

Interventions: intervention 1: BI 1744 intervention 2: BI 1744 intervention 3: Ketoconazole intervention 4: Ketoconazole
Intervention descriptions: intervention 1: 10 mcg solution for oral inhalation intervention 2: 10 mcg solution for oral inhalation intervention 3: 400 mg tablet intervention 4: 400 mg tablet

Protocol document: